Toxins from cone snails: Properties, applications and biotechnological production

Applied Microbiology and Biotechnology

Volumn 79, Issue 1, 2008, Pages 1-9

  Becker, Stefan ^a   Terlau, Heinrich ^b  

^a MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Conopeptides

Indexed keywords

CONE SNAILS; EUKARYOTIC EXPRESSION; PHARMACOLOGICAL PROPERTIES; VENOMS;

AMINO ACIDS; BIOSYNTHESIS; BIOTECHNOLOGY; LIGANDS; MEDICAL APPLICATIONS; PEPTIDES; TOXIC MATERIALS;

ANIMALS;

CONOPEPTIDE; CONOTOXIN; DELTA CONOTOXIN; KALIOTOXIN; KAPPA CONOTOXIN; KAPPA CONOTOXIN PVIIA; MU CONOTOXIN GIIIA; OMEGA CONOTOXIN; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIA; PEPTIDE DERIVATIVE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; ZICONITIDE;

BIOTECHNOLOGY; MEDICINE; PEPTIDE; SNAIL; TOXIN; VENOM;

AMINO ACID SEQUENCE; ANALGESIC ACTIVITY; BIOTECHNOLOGICAL PRODUCTION; CHEMICAL COMPOSITION; CLINICAL TRIAL; CONFORMATIONAL TRANSITION; DRUG MECHANISM; ESCHERICHIA COLI; HUMAN; INTRACTABLE PAIN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN MODIFICATION; PROTEIN STRUCTURE; SHORT SURVEY; SNAIL; SOLID PHASE SYNTHESIS; STRUCTURE ANALYSIS; SYNAPTIC TRANSMISSION; X RAY ANALYSIS;

ANALGESICS, NON-NARCOTIC; ANIMALS; CALCIUM CHANNELS, N-TYPE; CONOTOXINS; CONUS SNAIL; ESCHERICHIA COLI; OMEGA-CONOTOXINS; PICHIA; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EUKARYOTA; GASTROPODA; MOLLUSCA; PROKARYOTA;

EID: 40449127990     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-008-1385-6     Document Type: Short Survey

References (77)

1. Al-Sabi A, Lennartz D, Ferber M, Gulyas J, Rivier JE, Olivera BM, Carlomagno T, Terlau H (2004) KappaM-conotoxin RIIIK, structural and functional novelty in a K channel antagonist. Biochemistry 43:8625-8635
2. Bandyopadhyay PK, Colledge CJ, Walker CS, Zhou LM, Hillyard DR, Olivera BM (1998) Conantokin-G precursor and its role in gamma-carboxylation by a vitamin K-dependent carboxylase from a Conus snail (vol 273, pg 5447, 1998). J Biol Chem 273:14658-14658
3. Baneyx F (1999) Recombinant protein expression in Escherichia coli. Current Opinion in Biotechnology 10:411-421
4. Bayrhuber M, Vijayan V, Ferber M, Graf R, Korukottu J, Imperial J, Garrett JE, Olivera BM, Terlau H, Zweckstetter M et al (2005) Conkunitzin-S1 is the first member of a new Kunitz-type neurotoxin family. Structural and functional characterization. J Biol Chem 280:23766-23770
5. Bayrhuber M, Graf R, Ferber M, Zweckstetter M, Imperial J, Garrett JE, Olivera BM, Terlau H, Becker S (2006) Production of recombinant Conkunitzin-S1 in Escherichia coli. Protein Expr Purif 47:640-644
6. Becker S, Atherton E, Gordon RD (1989) Synthesis and characterization of mu-conotoxin IIIa. Eur J Biochem 185:79-84
7. Buczek O, Bulaj G, Olivera BM (2005) Conotoxins and the posttranslational modification of secreted gene products. Cell Mol Life Sci 62:3067-3079
8. Bulaj G (2005) Formation of disulfide bonds in proteins and peptides. Biotechnol Adv 23:87-92
9. Butt TR, Jonnalagadda S, Monia BP, Sternberg EJ, Marsh JA, Stadel JM, Ecker DJ, Crooke ST (1989) Ubiquitin fusion augments the yield of cloned gene-products in Escherichia coli. Proc Natl Acad Sci USA 86:2540-2544
10. Cabral KMS, Almeida MS, Valente AP, Almeida FCL, Kurtenbach E (2003) Production of the active antifungal Pisum sativum defensin 1 (Psd1) in Pichia pastoris: overcoming the inefficiency of the STE13 protease. Protein Expr Purif 31:115-122
11. Chang CD, Meienhofer J (1978) Solid-phase peptide-synthesis using mild base cleavage of nalpha-fluorenylmethyloxycarbonylamino acids, exemplified by a synthesis of dihydrosomatostatin. Int J Pept Protein Res 11:246-249
12. Craig AG, Bandyopadhyay P, Olivera BM (1999) Post-translationally modified neuropeptides from Conus venoms. Eur J Biochem 264:271-275
13. Dawson PE, Kent SBH (2000) Synthesis of native proteins by chemical ligation. Ann Rev Biochem 69:923-960
14. Doyle DA, Cabral JM, Pfuetzner RA, Kuo AL, Gulbis JM, Cohen SL, Chait BT, MacKinnon R (1998) The structure of the potassium channel: molecular basis of K conduction and selectivity. Science 280:69-77
15. Ducancel F, Boulain JC, Tremeau O, Menez A (1989) Direct expression in E. coli of a functionally active protein A-snake toxin fusion protein. Protein Eng 3:139-143
16. Dy CY, Buczek P, Imperial JS, Bulaj G, Horvath MP (2006) Structure of conkunitzin-S1, a neurotoxin and Kunitz-fold disulfide variant from cone snail. Acta Crystallogr, D Biol Crystallogr 62:980-990
17. Escoubas P, Bernard C, Lambeau G, Lazdunski M, Darbon H (2003) Recombinant production and solution structure of PcTx1, the specific peptide inhibitor of ASIC1a proton-gated cation channels. Protein Sci 12:1332-1343
18. Esposito D, Chatterjee DK (2006) Enhancement of soluble protein expression through the use of fusion tags. Curr Opin Biotechnol 17:353-358
19. Fahnert B, Lilie H, Neubauer P (2004) Inclusion bodies: formation and utilisation. Adv Biochem Eng Biotechnol 89:93-142
20. Ferber M, Sporning A, Jeserich G, DelaCruz R, Watkins M, Olivera BM, Terlau H (2003) A novel Conus peptide ligand for K channels. J Biol Chem 278(4):2177-2183
21. Galesi AL, Pereira CA, Moraes AM (2007) Culture of transgenic Drosophila melanogaster Schneider 2 cells in serum-free media based on TC100 basal medium. Biotechnol J 2:1399-1407
22. Georgiou G, Valax P (1996) Expression of correctly folded proteins in Escherichia coli. Curr Opin Biotechnol 7:190-197
23. Gottesman S (1996) Proteases and their targets in Escherichia coli. Annu Rev Genet 30:465-506
24. Hillyard DR, Monje VD, Mintz IM, Bean BP, Nadasdi L, Ramachandran J, Miljanich G, Azimizoonooz A, Mcintosh JM, Cruz LJ et al (1992) A new Conus peptide ligand for mammalian presynaptic Ca2 channels. Neuron 9:69-77
25. Huo XD, Liu YY, Wang X, Ouyang PK, Niu ZD, Shi YH, Qiu BS (2007) Co-expression of human protein disulfide isomerase (hPDI) enhances secretion of bovine follicle-stimulating hormone (bFSH) in Pichia pastoris. Protein Expr Purif 54:234-239
26. Jacobsen RB, Koch ED, Lange-Malecki B, Stocker M, Verhey J, Van Wagoner RM, Vyazovkina A, Olivera BM, Terlau H (2000) Single amino acid substitutions in kappa-conotoxin PVIIA disrupt interaction with the Shaker K channel. J Biol Chem 275:24639-24644
27. Kapust RB, Waugh DS (1999) Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 8:1668-1674
28. Kristensen AK, Brunstedt J, Nielsen JE, Mikkelsen JD, Roepstorff P, Nielsen KK (1999) Processing, disulfide pattern, and biological activity of a sugar beet defensin, AX2, expressed in Pichia pastoris. Protein Expr Purif 16:377-387
29. Lange A, Giller K, Hornig S, Martin-Eauclaire MF, Pongs O, Becker S, Baldus M (2006) Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR. Nature 440:959-962
30. Lauber T, Marx UC, Schulz A, Kreutzmann P, Rosch P, Hoffmann S (2001) Accurate disulfide formation in Escherichia coli: overexpression and characterization of the first domain (HF6478) of the multiple Kazal-type inhibitor LEKTI. Protein Expr Purif 22:108-112
31. Lavallie ER, Diblasio EA, Kovacic S, Grant KL, Schendel PF, Mccoy JM (1993) A thioredoxin gene fusion expression system that circumvents inclusion body formation in the Escherichia coli cytoplasm. Bio-Technology 11:187-193
32. Legros C, Feyfant E, Sampieri F, Rochat H, Bougis PE, Martin-Eauclaire MF (1997) Influence of a NH2-terminal extension on the activity of KTX2, a K channel blocker purified from Androctonus australis scorpion venom. FEBS Lett 417:123-129
33. Legros C, Kaabi H, El Ayeb M, Ceard B, Vacher H, Bougis PE, Martin-Eauclaire MF (2001) Use of fusion protein constructs to generate potent immunotherapy and protection against scorpion toxins. Vaccine 20:934-942
34. Lehmann K, Hoffmann S, Neudecker P, Suhr M, Becker WM, Rosch P (2003) High-yield expression in Escherichia coli, purification, and characterization of properly folded major peanut allergen Ara h 2. Protein Expr Purif 31:250-259
35. Lovelace ES, Armishaw CJ, Colgrave ML, Wahlstrom ME, Alewood PF, Daly NL, Craik DJ (2006) Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter. J Med Chem 49:6561-6568
36. Lubbers NL, Campbell TJ, Polakowski JS, Bulaj G, Layer RT, Moore J, Gross GJ, Cox BF (2005) Postischemic administration of CGX-1051, a peptide from cone snail venom, reduces infarct size in both rat and dog models of myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 46:141-146
37. MacKinnon R, Cohen SL, Kuo AL, Lee A, Chait BT (1998) Structural conservation in prokaryotic and eukaryotic potassium channels. Science 280:106-109
38. Malakhov MP, Mattern MR, Malakhova OA, Drinker M, Weeks SD, Butt TR (2004) SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. J Struct Funct Genomics 5:75-86
39. Mathys S, Evans TC, Chute IC, Wu H, Chong S, Benner J, Liu XQ, Xu MQ (1999) Characterization of a self-splicing mini-intein and its conversion into autocatalytic N- and C-terminal cleavage elements: facile production of protein building blocks for protein ligation. Gene 231:1-13
40. Maurizi MR (1992) Proteases and protein-degradation in Escherichia coli. Experientia 48:178-201
41. Merrifield RB (1963) Solid phase peptide synthesis. 1. Synthesis of a tetrapeptide. J Am Chem Soc 85:2149-2154
42. Miljanich GP (2004) Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain. Curr Med Chem 11:3029-3040
43. Miller C (1995) The charybdotoxin family of K channel-blocking peptides. Neuron 15:5-10
44. Moroder L, Besse D, Musiol HJ, RudolphBohner S, Siedler F (1996) Oxidative folding of cystine-rich peptides vs regioselective cysteine pairing strategies. Biopolymers 40:207-234
45. Nygren PA, Stahl S, Uhlen M (1994) Engineering proteins to facilitate bioprocessing. Trends Biotechnol 12:184-188
46. Olivera BM (1997) EE Just lecture, 1996-Conus venom peptides, receptor and ion channel targets, and drug design: 50 million years of neuropharmacology. Mol Biol Cell 8:2101-2109
47. Olivera BM (2002) Conus venom peptides: reflections from the biology of clades and species. Ann Rev Ecol Syst 33:25-47
48. Olivera BM (2006) Conus peptides: biodiversity-based discovery and exogenomics. J Biol Chem 281:31173-31177
49. Olivera BM, Cruz LJ, Desantos V, Lecheminant GW, Griffin D, Zeikus R, Mcintosh JM, Galyean R, Varga J, Gray WR et al (1987) Neuronal calcium-channel antagonists-discrimination between calcium-channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry 26:2086-2090
50. Olivera BM, Rivier J, Clark C, Ramilo CA, Corpuz GP, Abogadie FC, Mena EE, Woodward SR, Hillyard DR, Cruz LJ (1990) Diversity of Conus neuropeptides. Science 249:257-263
51. Ozawa A, Cai Y, Lindberg I (2007) Production of bioactive peptides in an in vitro system. Anal Biochem 366:182-189
52. Perler FB, Adam E (2000) Protein splicing and its applications. Curr Opin Biotechnol 11:377-383
53. Peti W, Page R (2007) Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost. Protein Expr Purif 51:1-10
54. Pi C, Liu J, Wang L, Jiang X, Liu Y, Peng C, Chen S, Xu A (2007) Soluble expression, purification and functional identification of a disulfide-rich conotoxin derived from Conus litteratus. J Biotechnol 128:184-193
55. Pines O, Inouye M (1999) Expression and secretion of proteins in E. coli. Mol Biotechnol 12:25-34
56. Prinz WA, Aslund F, Holmgren A, Beckwith J (1997) The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm. J Biol Chem 272:15661-15667
57. Rabhi-Essafi I, Sadok A, Khalaf N, Fathallah DM (2007) A strategy for high-level expression of soluble and functional human interferon alpha as a GST-fusion protein in E. coli. Protein Eng Des Sel 20:201-209
58. Rivier J, Galyean R, Gray WR, Azimi-Zonooz A, McIntosh JM, Cruz LJ, Olivera BM (1987) Neuronal calcium channel inhibitors. Synthesis of omega-conotoxin GVIA and effects on 45Ca uptake by synaptosomes. J Biol Chem 262:1194-1198
59. Rudolph R, Lilie H (1996) In vitro folding of inclusion body proteins. Faseb J 10:49-56
60. Saleh L, Perler FB (2006) Protein splicing in cis and in trans. Chem Rec 6:183-193
61. Schmoldt HU, Wentzel A, Becker S, Kolmar H (2005) A fusion protein system for the recombinant production of short disulfide bond rich cystine knot peptides using barnase as a purification handle. Protein Expr Purif 39:82-89
62. Shon KJ, Stocker M, Terlau H, Stuhmer W, Jacobsen R, Walker C, Grilley M, Watkins M, Hillyard DR, Gray WR et al (1998) kappa-Conotoxin PVIIA is a peptide inhibiting the shaker K channel. J Biol Chem 273:33-38
63. Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce DA, Mangieri EA, Luther RR et al (2004) Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. Jama 291:63-70
64. Stanley TB, Stafford DW, Olivera BM, Bandyopadhyay PK (1997) Identification of a vitamin K-dependent carboxylase in the venom duct of a Conus snail. Febs Lett 407:85-88
65. Stix G (2005) A toxin against pain. Sci Am 292:88-93
66. Terlau H, Olivera BM (2004) Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol Rev 84:41-68
67. Terlau H, Shon KJ, Grilley M, Stocker M, Stuhmer W, Olivera BM (1996) Strategy for rapid immobilization of prey by a fish-hunting marine snail. Nature 381:148-151
68. Tsai CW, Duggan PF, Shimp RL, Miller LH, Narum DL (2006) Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris. J Biotechnol 121:458-470
69. Vad R, Nafstad E, Dahl LA, Gabrielsen OS (2005) Engineering of a Pichia pastoris expression system for secretion of high amounts of intact human parathyroid hormone. J Biotechnol 116:251-260
70. Verdier L, Al-Sabi A, Rivier JEF, Olivera BM, Terlau H, Carlomagno T (2005) Identification of a novel pharmacophore for peptide toxins interacting with K channels. J Biol Chem 280:21246-21255
71. Vogel CW, Fritzinger DC, Hew BE, Thorne M, Bammert H (2004) Recombinant cobra venom factor. Mol Immunol 41:191-199
72. White CE, Kempi NM, Komives EA (1994) Expression of highly disulfide-bonded proteins in Pichia pastoris. Structure 2:1003-1005
73. Wood DW, Wu W, Belfort G, Derbyshire V, Belfort M (1999) A genetic system yields self-cleaving inteins for bioseparations. Nat Biotechnol 17:889-892
74. Wu H, Xu MQ, Liu XQ (1998) Protein trans-splicing and functional mini-inteins of a cyanobacterial dnaB intein. Biochim Biophys Acta 1387:422-432
75. Xia Z, Chen Y, Zhu Y, Wang F, Xu X, Zhan J (2006) Recombinant omega-conotoxin MVIIA possesses strong analgesic activity. BioDrugs 20:275-281
76. Xiong S, Wang YF, Ren XR, Li B, Zhang MY, Luo Y, Zhang L, Xie QL, Su KY (2005) Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its "oxidizing" mutant. World J Gastroenterol 11:1077-1082
77. Zhang SJ, Yang XM, Liu GS, Cohen MV, Pemberton K, Downey JM (2003) CGX-1051, a peptide from conus snail venom, attenuates infarction in rabbit hearts when administered at reperfusion. J Cardiovasc Pharmacol 42:764-771